風華高科(000636.SZ):一季度核心汽車電子客户出貨量持續提升 新客户訂單交付實現突破
格隆匯5月14日丨風華高科(000636.SZ)近日在接待機構投資者調研時表示,目前公司車規品已從原有的車載周邊進入到電驅、BMS、OBC、電控等車身核心關鍵系統,並已推出30餘款車規級被動元器件產品系列,涵蓋MLCC、片式電阻、電感等產品,車規物料規格持續增加,車規品交付能力持續提升,下游整車廠及tier1廠客户持續豐富。2024年一季度,公司核心汽車電子客户出貨量持續提升,新客户訂單交付實現突破。未來公司將加快更多新客户的市場開拓,並提升現有大客户供應份額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.